Skip to main content
Glama

longevitypulse

Interpret biomarkers, build personalized longevity protocols, and research evidence-based supplements, clinical trials, and Blue Zones worldwide.

Instructions

LongevityPulse: Global longevity intelligence API — biomarker interpretation, supplement evidence, personalized protocols, clinical trials, Blue Zone research, WHO country longevity profiles, epigenetic clocks, dieta

Coverage: Global

Endpoints: • biomarker ($0.10): Biomarker interpretation through longevity science lens • supplement-intel ($0.10): Evidence-graded longevity supplement intelligence • protocol-builder ($0.10): Personalized longevity protocol — exercise, nutrition, sleep, supplements • clinical-trials ($0.10): Search active longevity clinical trials globally from ClinicalTrials.gov • blue-zone ($0.10): Blue Zone intelligence — world longevity hotspots deep-dive • country-longevity ($0.10): WHO country longevity profile — life expectancy, HALE, healthcare, initiatives • epigenetic-clock ($0.10): Epigenetic aging clocks — biological age science, testing, and reversal • diet-intel ($0.10): Evidence-graded dietary analysis for longevity and healthspan • longevity-drug ($0.10): Pharmaceutical longevity intelligence — rapamycin, metformin, senolytics • longevity-clinic ($0.10): Global longevity clinic guide — destinations, treatments, red flags

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
actionYesWhich endpoint to call. Options: biomarker | supplement-intel | protocol-builder | clinical-trials | blue-zone | country-longevity | epigenetic-clock | diet-intel | longevity-drug | longevity-clinic
langNoResponse language: en|es|fr|de|ja|zh|ko|pt|ar|hi (default: en)
biomarkerNoBiomarker name — e.g. ApoB | hs-CRP | HbA1c | testosterone | IGF-1 | homocysteine | Lp(a) | ferritin | vitamin D | DHEA-S
valueNoLab result with unit — e.g. 85 mg/dL | 2.1 mg/L | 5.4% | 420 ng/dL (optional — enables personalized assessment)
compoundNoCompound name — e.g. NMN | NR | berberine | spermidine | urolithin A | fisetin | quercetin | alpha-ketoglutarate | resveratrol | taurine
ageNoAge in years — e.g. 35 | 52 | 65
sexNoBiological sex — male | female
goalsNoLongevity goals — e.g. maximize healthspan | cardiovascular health | cognitive longevity | muscle preservation | reverse biological age
conditionsNoHealth conditions — e.g. type 2 diabetes | hypertension | none
budgetNoBudget level — low | moderate | high | $200/month
conditionNoCondition or intervention — e.g. aging | rapamycin | metformin | NMN | senolytics | caloric restriction | Alzheimer prevention
recruiting_onlyNoShow only recruiting trials (default: true)
zoneNoBlue Zone or region — e.g. Okinawa | Sardinia | Ikaria | Nicoya | Loma Linda | Blue Zones overview | Hunza | Vilcabamba
countryNoCountry name — e.g. Japan | Singapore | Spain | South Korea | Switzerland | Costa Rica | Australia | United States | India | Nigeria
topicNoTopic — e.g. GrimAge | DunedinPACE | biological age overview | how to reverse biological aging | epigenetic reprogramming | how to test biol
dietNoDiet pattern — e.g. Mediterranean | time-restricted eating | fasting mimicking diet | Blue Zone plant-based | MIND diet | caloric restrictio
drugNoDrug name — e.g. rapamycin | metformin | acarbose | dasatinib | fisetin | senolytics | empagliflozin | semaglutide
treatmentNoTreatment of interest — e.g. stem cell therapy | NAD+ IV | peptide therapy | hyperbaric oxygen | plasmapheresis | ozone therapy
Behavior2/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations are provided, so the description carries the full burden. It lists endpoints and mentions pricing per call, but does not disclose whether operations are read-only, any rate limits, or potential side effects. The description is insufficient for an agent to understand behavioral traits.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness2/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is overly verbose, including a tagline, coverage statement, pricing, and a list of endpoints with examples. It could be condensed to a few sentences. Important information like how to choose an endpoint is buried. It lacks front-loading of the core action.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (18 parameters, 10 endpoints), the description covers the range of actions by listing endpoints and example values. However, it lacks context on return values (no output schema), behavioral details, and when to use specific endpoints. It is moderately complete but has clear gaps.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the schema already documents each parameter. The description adds example values for many parameters (e.g., biomarker: 'ApoB', 'hs-CRP'), which provides context but is largely redundant. The description does not significantly reduce ambiguity beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states it's a 'Global longevity intelligence API' and lists endpoints like biomarker, supplement-intel, etc., distinguishing it from sibling tools that focus on other domains. However, the description includes marketing fluff and pricing that obscures the core purpose.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines2/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

No explicit guidance on when to use this tool vs alternatives. The description lists many endpoints but does not clarify when to choose one endpoint over another or provide context for avoiding misuse. Given the many sibling tools, such guidance is lacking.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Install Server

Other Tools

Latest Blog Posts

MCP directory API

We provide all the information about MCP servers via our MCP API.

curl -X GET 'https://glama.ai/api/mcp/v1/servers/GTCC777/pulsenetwork-mcp'

If you have feedback or need assistance with the MCP directory API, please join our Discord server